Ownership history in DAGCO, INC. · 3 quarters on record
This page tracks every 13F SEC filing in which DAGCO, INC. reported a position in MEDICUS PHARMA LTD (MDCX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 349 | — | 0% | 0.00% | $534 | $1.53 |
| 2025 Q3 | REDUCED | 349 | -1 | -0.3% | 0.00% | $808 | $2.32 |
| 2025 Q2 | INITIATED | 350 | — | — | 0.00% | $1K | $2.99 |
As of 2025 Q4 — sorted by position size